- Attitudes among pediatric residents toward patients with sickle cell disease (SCD) lead to undertreatment for pain.
Why this matters
- "Current guidelines recommend high-priority treatment of severe [SCD] pain with opioids," say researchers. "[R]esidents that we surveyed reported concerns about tolerance and dependence as major barriers to use of opioids in treatment of acute pain in SCD."
- Researchers surveyed residents at an urban pediatric medical center (N=53) about acute SCD pain management, classifying them as either "more experienced" (had seen ≥21 patients with SCD; 45.3%) or "less experienced."
- Funding: NIH.
- Both more and less experienced residents reported that potential tolerance and dependence were major barriers to opioid use in SCD.
- A greater need for additional training in SCD pain management (P<.05 was reported by less experienced residents as were concern about addiction and greater empathy for patients with scd>
- The study was single-center with a small sample size.
- The surveys were subject to self-reporting bias.